2025³â 08¿ù 08ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92606°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



GS25 ¡®»ý°úÀÏ ½º¹«µð¡¯ ¿î¿µÁ¡ ±âÁØ Àüü ÆÇ¸Å·® 3À§

2030 ¼¼´ë°¡ °í°´ 69.5%
GS25°¡ ¾÷°è ÃÖÃÊ·Î ¼±º¸ÀÎ »ý°úÀÏ ½º¹«µð Àü¿ë ±â±â GS¸®Å×ÀÏÀÌ ¿î¿µÇÏ´Â ÆíÀÇÁ¡ GS25°¡ º»°ÝÀûÀÎ ¹«´õÀ§¸¦ ¸Â¾Æ ÃÖ±Ù 2ÁÖ°£(6/23~7/6) ‘»ý°úÀÏ ½º¹«µð’ ¿î¿µ Á¡Æ÷ 20¿© °÷À» ´ë»óÀ¸·Î ÆÇ¸Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ °á°ú »ý°úÀÏ ½º¹«µð°¡ ‘Ä«Æä25 ¾Æ¸Þ¸®Ä«³ë’, ‘ÄÅ ¾óÀ½’¿¡ À̾î Àüü ÆÇ¸Å·® 3À§(´ã¹è Á¦¿Ü)¿¡ µî±ØÇÑ °ÍÀ¸·Î ºÐ¼®µÆ´Ù. GS25´Â Áö³­ÇØ 12¿ù ÆíÀÇÁ¡ ¾÷°è ÃÖÃÊ·Î Á÷¿µÁ¡ ÇѰ÷À» ÅëÇØ Áï¼® »ý°úÀÏ ½º¹«µð¸¦ ¼±º¸¿´´Ù. ÃֽŠ¸Ô°Å¸® Æ®·»µå¸¦ ¼±Á¡ÇϰíÀÚ ÆíÀÇÁ¡ Ư¼º¿¡ ¸Â´Â Àü¿ë ±â±â ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
HKTB to Boost the City¡¯s Recovery Through New ¡°Hong Kong S... (2021-02-15)
Yokogawa Successfully Completes Proof of Concept for Optimiz... (2022-03-31)
ÀÌÈ¥ÇÏÁö ¾Ê°í Àç»êºÐÇÒ ¹Þ´Â ¹æ¹ý (2013-04-27)
iCOOP»ýÇù, ¼¼°è ÃÖÃÊ °øÁ¤¹«¿ª ÀÎÁõ ¿ÍÀΠźµð¿ÍÀÎ ÆÇ¸Å (2013-05-09)
Áß°í¸íǰ Ç÷§Æû Äíµ·, ¸ÅÀÔ¡¤ÆÇ¸Å À̺¥Æ® (2020-01-27)
¡®½ºÅ¸¸®¾Æ¡¯ ƼÀú À̹ÌÁö ¼¼°è ÃÖÃÊ °ø°³ (2021-03-11)
¿¬¼¼´ë À̰ú ³í¼ú, ¼ö¸® 60%¡¤°úÇÐ 40% ºñÁßÀ¸·Î ÃâÁ¦ (2013-08-13)
Çö´ë¼º¿ì±×·ì, ·¹ÀÌ½Ì À¯¸ÁÁÖ À°¼º À̾´Ù (2021-04-16)
Àº´Ð±â´É °®Ãá ÃÖ÷´Ü ½ºÆÄÀÌ¿þ¾î ·¹±ä Æ÷Âø (2014-11-25)
LintonPharm to Release Data on Catumaxomab for Advanced Gast... (2022-05-30)
¡®Ä¡¸Æ¡¯ÀÇ Èû¡¦Á¡Æ÷ ±Ç¸®±Ýµµ ¡®ÁÂÁö¿ìÁö¡¯ (2013-11-29)
Àç±Ô¾î, º¼º¸, Åä¿äŸ ÀÚµ¿Â÷ ¸®ÄÝ (2013-12-23)
KT, ´õ Ŭ·¡½Ä 500°ú ÀΰøÁö´É ½Ã´Ï¾îŸ¿î ¸¸µç´Ù (2019-04-13)
¹Úö¹Î ÇÔ²²ÇÏ´Â Ä¡¸Å°¡Á¤Áö¿øÄ·ÆäÀÎ 'À̸§À» Àؾ' (2018-06-28)
±èÀçȯ, ¡®º¸À̽º4¡¯ OST ´ë¹Ì Àå½ÄÇß´Ù (2021-07-21)
80.6%, ½º¸¶Æ®±â±â Ȱ¿ëÇØ ÇнÀ (2019-07-18)
ÀڱñÙÁ¾°ú ¸Ô´Â ÇÇÀÓ¾à, ¾î¶² °ü°è°¡ ÀÖÀ»±î (2013-08-12)
µÎ ¹ø ž ¹Ì¼úÀÛǰ, ¡®2013¿òÁ÷ÀÓ¡¯ °ú ¡®2013Æ÷Áî1¡¯ (2013-08-12)
ÀϺ»¹ß ¹«¿ªÀüÀï, ºÐ¼®±â¼ú°ú Àåºñ°¡ °ü°Ç (2019-08-11)
±ÝÀ¶¾÷°è ´ë»ó Å©¸®µ§¼È ½ºÅÍÇÎ °ø°Ý 35¾ï°Ç (2019-08-11)
ÇÁ¸®¹Ì¾ö ÃÊÄݸ´ ºê·£µå '¼Õư½º' īī¿ÀÅå ¼±¹°Çϱâ (2019-08-11)
MarineMax To Acquire IGY Marinas Significantly Expanding Glo... (2022-08-10)
°Ç±¹´ë, È«¼ö ÇÇÇØ Çлý¿¡ ¡®ÀçÇØ Ưº°ÀåÇбݡ¯ Áö¿ø (2020-08-30)
ºñµÑ±â ºñÇà °¡»ó ÀçÇö±â¼ú °³¹ß (2013-10-23)
±â¾÷µé 2021³â MBA Á¹¾÷»ý ä¿ë ÀÇ»ç ³ô¾Æ (2020-10-05)
       [ÀÌÀü][1]....[3486][3487][3488][3489][3490][3491][3492][3493][3494]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..